Literature DB >> 1387004

A prospective evaluation of the cumulative illness rating scale.

E Waldman1, J F Potter.   

Abstract

Assessment of overall physical health is an important yet little studied problem in geriatric research. The Cumulative Illness Rating Scale (CIRS) was among the first instruments that attempted to summarize the overall severity of illness based on clinical information. This study evaluated the CIRS in a prospective longitudinal study of 181 elderly (mean age +/- SD = 79 +/- 7.4) subjects undergoing comprehensive geriatric assessment in an outpatient unit. The CIRS was found to correlate negatively with activities of daily living (r = -0.49, p = 0.0001), instrumental activities of daily living (r = -0.34, p = 0.0001), patient morale (r = -0.30, p = 0.0001), and positively with days in hospital (r = 0.21, p = 0.0075) and number of medications (r = 0.31, p = 0.0001). Mean CIRS scores for subjects who died during follow-up were significantly higher than the scores for survivors (p less than 0.01). In logistic regression, CIRS was a significant predictor of death, yet it did not improve that prediction over information contained in measures of activities of daily living. In separate logistic analyses, CIRS and age predicted acute care hospital days during follow-up, while ADL or IADL predicted the use of nursing home services. Although the CIRS appears to be a reliable method of summarizing medical information and to have some external validity, in its present form it does not provide additional prognostic information.

Entities:  

Mesh:

Year:  1992        PMID: 1387004     DOI: 10.1007/bf03324087

Source DB:  PubMed          Journal:  Aging (Milano)        ISSN: 0394-9532


  8 in total

1.  Multimorbidity and Opioid Prescribing in Hospitalized Older Adults.

Authors:  Sarah Schear; Kanan Patel; Lisa X Deng; Christine Miaskowski; Ingrid Maravilla; Sarah K Garrigues; Nicole Thompson; Andrew D Auerbach; Christine S Ritchie
Journal:  J Palliat Med       Date:  2019-11-05       Impact factor: 2.947

2.  A cardiovascular disease risk prediction algorithm for use with the Medicare current beneficiary survey.

Authors:  Hassan Fouayzi; Arlene S Ash; Amy K Rosen
Journal:  Health Serv Res       Date:  2020-04-14       Impact factor: 3.402

3.  Personality and physician-assessed illness burden in older primary care patients over 4 years.

Authors:  Benjamin P Chapman; Brent Roberts; Jeff Lyness; Paul Duberstein
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

4.  Construction of a comorbidity index for prostate cancer patients linking state cancer registry with inpatient and outpatient data.

Authors:  Hong Xiao; Fei Tan; Pierre Goovaerts; Askal Ali; Georges Adunlin; Youjie Huang; Clement Gwede
Journal:  J Registry Manag       Date:  2013

5.  A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index.

Authors:  B Colinet; W Jacot; D Bertrand; S Lacombe; M-C Bozonnat; J-P Daurès; J-L Pujol
Journal:  Br J Cancer       Date:  2005-11-14       Impact factor: 7.640

6.  IMPOSE (IMProving Outcomes after Sepsis)-the effect of a multidisciplinary follow-up service on health-related quality of life in patients postsepsis syndromes-a double-blinded randomised controlled trial: protocol.

Authors:  Jennifer D Paratz; Justin Kenardy; Geoffrey Mitchell; Tracy Comans; Fiona Coyer; Peter Thomas; Sunil Singh; Louise Luparia; Robert J Boots
Journal:  BMJ Open       Date:  2014-05-26       Impact factor: 2.692

7.  Comorbidities of idiopathic thrombocytopenic purpura: a population-based study.

Authors:  M A Feudjo-Tepie; G Le Roux; K J Beach; D Bennett; N J Robinson
Journal:  Adv Hematol       Date:  2009-04-02

8.  Dynamic SOFA score assessments to predict outcomes after acute admission of octogenarians to the intensive care unit.

Authors:  Emmanuelle Loyrion; Lydiane Agier; Thibaut Trouve-Buisson; Gaetan Gavazzi; Carole Schwebel; Jean-Luc Bosson; Jean-François Payen
Journal:  PLoS One       Date:  2021-08-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.